
Glimnof PM 2mg/500mg/15mg Tablet
Marketer
Cenofi Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimnof PM 2mg/500mg/15mg Tablet
Glimepiride-metformin-pioglitazone 2mg/500mg/15mg tablets offer a combined approach to managing elevated blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, near the time of the next dose, omit the missed dose and resume the regular schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse reactions may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function assessment will be conducted before treatment initiation. Limit alcohol consumption to mitigate the potential for increased side effects.
Uses of Glimnof PM 2mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glimnof PM 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Glimnof PM 2mg/500mg/15mg tablets with a meal.
Common Side effects of Glimnof PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimnof PM 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Glimnof PM 2mg/500mg/15mg Tablet with a meal.
How Glimnof PM 2mg/500mg/15mg Tablet works:
Glimnof PM 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further augmenting insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimnof PM 2mg/500mg/15mg tablets is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimnof PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Glimnof PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimnof PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The use of Glimnof PM 2mg/500mg/15mg tablets is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimnof PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimnof PM 2mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimnof PM 2mg/500mg/15mg Tablet :
Should you forget to take your Glimnof PM 2mg/500mg/15mg Tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take more than the prescribed dose.
Facts to Know About Glimnof PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
